Aspen Pharmacare Cash on Hand 2017-2025 | APNHY
Aspen Pharmacare cash on hand from 2017 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Aspen Pharmacare Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $353 |
| 2024 | $660 |
| 2023 | $615 |
| 2022 | $407 |
| 2021 | $557 |
| 2020 | $457 |
| 2019 | $633 |
| 2018 | $872 |
| 2017 | $786 |
| 2016 | $756 |
|
Aspen Pharmacare Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-12-31 | $328 |
| 2025-06-30 | $353 |
| 2024-12-31 | $380 |
| 2024-06-30 | $660 |
| 2023-12-31 | $619 |
| 2023-06-30 | $615 |
| 2022-12-31 | $457 |
| 2022-06-30 | $407 |
| 2021-12-31 | $512 |
| 2021-06-30 | $557 |
| 2020-12-31 | $629 |
| 2020-06-30 | $457 |
| 2019-06-30 | $633 |
| 2018-12-31 | $690 |
| 2018-06-30 | $872 |
| 2017-12-31 | $625 |
| 2017-06-30 | $786 |
| 2016-12-31 | $682 |
| 2016-06-30 | $756 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $4.248B | $2.065B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $45.423B | 17.88 |
| BridgeBio Pharma (BBIO) | United States | $13.021B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $10.175B | 25.94 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.445B | 20.49 |
| Bausch Health Cos (BHC) | Canada | $2.121B | 1.32 |
| Personalis (PSNL) | United States | $1.717B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.636B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.005B | 9.45 |
| Assembly Biosciences (ASMB) | United States | $0.508B | 24.48 |
| Sol-Gel Technologies (SLGL) | Israel | $0.169B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.042B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |